A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China

A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06672393 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

NCT06926582 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

NCT07256015 ·Status: RECRUITING

A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06077331 ·Status: RECRUITING ·Phase: PHASE2

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

NCT04908189 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis

NCT04772079 ·Status: RECRUITING ·Phase: PHASE3

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

NCT05744466 ·Status: RECRUITING

A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis

NCT05547490 ·Status: COMPLETED

An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis

NCT05124080 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

NCT05478499 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

NCT06122649 ·Status: COMPLETED ·Phase: PHASE3

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

NCT06143878 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis

NCT05120297 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Moderate to Severe Plaque Psoriasis

NCT06542614 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

NCT06952465 ·Status: ACTIVE_NOT_RECRUITING

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

NCT04908202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

NCT06011733 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis

NCT07129382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea

NCT06258668 ·Status: RECRUITING

A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)

NCT06701513 ·Status: RECRUITING

A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China

NCT04894890 ·Status: COMPLETED

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

NCT02595970 ·Status: COMPLETED ·Phase: PHASE3

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

NCT04036435 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis

NCT01646073 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants

NCT04316585 ·Status: COMPLETED ·Phase: PHASE1